Dual clinical remission in patients treated with biologics for severe asthma and eosinophilic chronic rhinosinusitis

Key Findings

• ●Dual clinical remission achieved in 25% of patients with both severe asthma and eosinophilic CRS on biologics
• ●CRS remission rate (60%) higher than asthma remission (37%)
• ●Age ≥65 and N-ERD comorbidity are predictors of dual remission

Referenced in (1 disease)